Recombinant Proteins Manufacturing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service Type (Pre-clinical & Clinical Services, Commercial Production Services), By Host Cell (Mammalian Cells, Bacterial Cells, Insect Cells, Yeast & Fungi, Others), By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), By Region and Competition, 2020-2030F

November 2025 | 185 pages | ID: RC722758E056EN
TechSci Research

Abstracts

The Global Recombinant Proteins Manufacturing Services Market, valued at USD 3.76 Billion in 2024, is projected to experience a CAGR of 7.41% to reach USD 5.77 Billion by 2030. Recombinant proteins are artificially engineered proteins generated by introducing specific genetic material into host cells, enabling their large-scale production for diverse applications, including therapeutic, diagnostic, and research purposes. The market for manufacturing services in this sector is fundamentally driven by increasing global investments in biopharmaceutical research and development, the expanding demand for biologics and biosimilars, and the growing prevalence of chronic diseases requiring advanced protein-based therapies.

Key Market Drivers

The rising demand for biologics and biosimilars is a primary driver for the global recombinant proteins manufacturing services market. These advanced therapeutic products, leveraging recombinant protein technology, address diverse diseases, and their growing adoption demands specialized production capabilities. Patent expirations for originator biologics have notably fueled the biosimilars sector, increasing product development. Recombinant protein service manufacturers are crucial in supporting this pipeline, providing expertise and infrastructure for complex biological production. This pursuit of more affordable treatments strengthens market demand; according to a study published by RAND Corporation in January 2022, biosimilar drugs are expected to generate savings estimated at USD 38.4 billion of projected total U. S. expenditure on biologics from 2021 to 2025. This economic benefit underscores the need for efficient and scalable manufacturing services.

Key Market Challenges

The inherent complexities in achieving optimal protein expression, ensuring high purity during purification, and maintaining consistent product quality and stability pose a significant impediment to the growth of the global recombinant proteins manufacturing services market. These technical hurdles, including issues such as protein aggregation and the necessity for stringent regulatory compliance across diverse expression systems, directly lead to elevated operational costs and extended development timelines for recombinant protein products. This significantly increases the financial burden on manufacturers and developers.

Key Market Trends

The expansion of biopharmaceutical outsourcing to specialized providers continues to significantly shape the Global Recombinant Proteins Manufacturing Services Market. This trend reflects a strategic shift by pharmaceutical and biotechnology companies to leverage external expertise, advanced technologies, and scalable capacity offered by contract development and manufacturing organizations. This allows companies to optimize resource allocation, reduce capital expenditure, and accelerate time to market for complex protein-based therapies. Lonza's CDMO business, for instance, reported robust performance in its first half of 2025, with sales delivering a 23.1% growth at constant exchange rates. This substantial growth underscores the sustained demand for specialized outsourcing services within the industry.

Key Market Players

• Lonza Group Ltd.
• Boehringer Ingelheim International GmbH
• FUJIFILM Diosynth Biotechnologies USA, Inc.
• Merck KGaA
• Bruker Corporation
• Sino Biological, Inc.
• GenScript Biotech Corporation
• Kaneka Corporation
• Polyplus Transfection S.A.
• Boster Biological Technology Co., Ltd.

Report Scope:

In this report, the Global Recombinant Proteins Manufacturing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Recombinant Proteins Manufacturing Services Market, By Service Type:
• Pre-clinical & Clinical Services
• Commercial Production Services
• Recombinant Proteins Manufacturing Services Market, By Host Cell:
• Mammalian Cells
• Bacterial Cells
• Insect Cells
• Yeast & Fungi
• Others
• Recombinant Proteins Manufacturing Services Market, By End-user:
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Recombinant Proteins Manufacturing Services Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Recombinant Proteins Manufacturing Services Market.

Available Customizations:

Global Recombinant Proteins Manufacturing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Service Type (Pre-clinical & Clinical Services, Commercial Production Services)
  5.2.2. By Host Cell (Mammalian Cells, Bacterial Cells, Insect Cells, Yeast & Fungi, Others)
  5.2.3. By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes)
  5.2.4. By Region
  5.2.5. By Company (2024)
5.3. Market Map

6. NORTH AMERICA RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Service Type
  6.2.2. By Host Cell
  6.2.3. By End-user
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Recombinant Proteins Manufacturing Services Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Service Type
      6.3.1.2.2. By Host Cell
      6.3.1.2.3. By End-user
  6.3.2. Canada Recombinant Proteins Manufacturing Services Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Service Type
      6.3.2.2.2. By Host Cell
      6.3.2.2.3. By End-user
  6.3.3. Mexico Recombinant Proteins Manufacturing Services Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Service Type
      6.3.3.2.2. By Host Cell
      6.3.3.2.3. By End-user

7. EUROPE RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Service Type
  7.2.2. By Host Cell
  7.2.3. By End-user
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Recombinant Proteins Manufacturing Services Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Service Type
      7.3.1.2.2. By Host Cell
      7.3.1.2.3. By End-user
  7.3.2. France Recombinant Proteins Manufacturing Services Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Service Type
      7.3.2.2.2. By Host Cell
      7.3.2.2.3. By End-user
  7.3.3. United Kingdom Recombinant Proteins Manufacturing Services Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Service Type
      7.3.3.2.2. By Host Cell
      7.3.3.2.3. By End-user
  7.3.4. Italy Recombinant Proteins Manufacturing Services Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Service Type
      7.3.4.2.2. By Host Cell
      7.3.4.2.3. By End-user
  7.3.5. Spain Recombinant Proteins Manufacturing Services Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Service Type
      7.3.5.2.2. By Host Cell
      7.3.5.2.3. By End-user

8. ASIA PACIFIC RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Service Type
  8.2.2. By Host Cell
  8.2.3. By End-user
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Recombinant Proteins Manufacturing Services Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Service Type
      8.3.1.2.2. By Host Cell
      8.3.1.2.3. By End-user
  8.3.2. India Recombinant Proteins Manufacturing Services Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Service Type
      8.3.2.2.2. By Host Cell
      8.3.2.2.3. By End-user
  8.3.3. Japan Recombinant Proteins Manufacturing Services Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Service Type
      8.3.3.2.2. By Host Cell
      8.3.3.2.3. By End-user
  8.3.4. South Korea Recombinant Proteins Manufacturing Services Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Service Type
      8.3.4.2.2. By Host Cell
      8.3.4.2.3. By End-user
  8.3.5. Australia Recombinant Proteins Manufacturing Services Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Service Type
      8.3.5.2.2. By Host Cell
      8.3.5.2.3. By End-user

9. MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Service Type
  9.2.2. By Host Cell
  9.2.3. By End-user
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Recombinant Proteins Manufacturing Services Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Service Type
      9.3.1.2.2. By Host Cell
      9.3.1.2.3. By End-user
  9.3.2. UAE Recombinant Proteins Manufacturing Services Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Service Type
      9.3.2.2.2. By Host Cell
      9.3.2.2.3. By End-user
  9.3.3. South Africa Recombinant Proteins Manufacturing Services Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Service Type
      9.3.3.2.2. By Host Cell
      9.3.3.2.3. By End-user

10. SOUTH AMERICA RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Service Type
  10.2.2. By Host Cell
  10.2.3. By End-user
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Recombinant Proteins Manufacturing Services Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Service Type
      10.3.1.2.2. By Host Cell
      10.3.1.2.3. By End-user
  10.3.2. Colombia Recombinant Proteins Manufacturing Services Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Service Type
      10.3.2.2.2. By Host Cell
      10.3.2.2.3. By End-user
  10.3.3. Argentina Recombinant Proteins Manufacturing Services Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Service Type
      10.3.3.2.2. By Host Cell
      10.3.3.2.3. By End-user

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Lonza Group Ltd.
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Boehringer Ingelheim International GmbH
15.3. FUJIFILM Diosynth Biotechnologies USA, Inc.
15.4. Merck KGaA
15.5. Bruker Corporation
15.6. Sino Biological, Inc.
15.7. GenScript Biotech Corporation
15.8. Kaneka Corporation
15.9. Polyplus Transfection S.A.
15.10. Boster Biological Technology Co., Ltd.

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER